Legend Biotech (LEGN) Share-based Compensation (IS) (2023 - 2025)
Legend Biotech (LEGN) reported Share-based Compensation (IS) of $14.9 million for Q4 2025, up 11.19% on a YoY basis from $13.4 million in Q4 2024, and up 11.19% quarter-over-quarter from $13.4 million in Q4 2024.
Legend Biotech (LEGN) Share-based Compensation (IS) (2023 - 2025) Analysis & Trends
Legend Biotech has reported Share-based Compensation (IS) for 3 years, with the latest figure at $14.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (IS) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.45 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 892,057.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 14.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.90 Mn |
| Dec 31, 2025 | 14.90 Mn |
| Dec 31, 2024 | 13.40 Mn |
| Dec 31, 2024 | 13.40 Mn |
| Dec 31, 2023 | 12.59 Mn |
| Dec 31, 2023 | 12.59 Mn |